Normal Human CD8+ Cytotoxic T Cells INTRODUCTION

Normal Human CD8+ Cytotoxic T Cells
Catalog #
PBMC004A
Shipping and
Storage:
Description/Content
Normal Human CD8+ Cytotoxic T
Cells (negatively selected),
Cryopreserved
Amount
10.0 x
106
cells
Cells are shipped on dry ice. For maximum
viability, it is best to use cells as soon as
possible. For short term (3 weeks or less) store
cells at -80ºC; for longer term, store cells in liquid
nitrogen (-170ºC). NOTE: viability cannot be
guaranteed following -170ºC storage or beyond one
week at -80ºC.
A division of Gene Therapy Systems, Inc.
Related Products
Catalog Numbers
Normal Human Peripheral Blood Mononuclear
Cells
PBMC000 (5.0x106);
PBMC001 (25.0x106);
PBMC002 (75.0x106).
Normal Human CD4+ Helper T Cells
PBMC003A (10.0x106).
Normal Human CD14+ Monocytes
PBMC005A (10.0x106).
Normal Human CD19+ B Cells
PBMC006A (10.0x106).
Normal Human CD56+ Natural Killer Cells
PBMC007A (10.0x106).
Normal Human Dendritic Cells
PBMC008A (0.5x106).
INTRODUCTION
Normal Human CD8+ Cytotoxic T Cells are a sub-group of T lymphocytes capable of inducing the death of infected -with viruses or other pathogenssomatic or tumor cells. Most CD8+ Cytotoxic T cells express T-cell receptors that can recognize a specific antigenic peptide bound to Class I MHC
molecules (present on all nucleated cells) and a glycoprotein called CD8. The MHC molecule keeps the Cytotoxic T cell and the target cell bound
closely together during antigen-specific activation. CD8+ T cells are recognized as Cytotoxic T cells once they become activated and are generally
classified as having a pre-defined cytotoxic role within the immune system. The ImmunoPure HD CD8+ Cytotoxic T Cells are isolated from fresh
human adult peripheral blood of healthy donors at IRB-approved and FDA-licensed blood banks, using apheresis and immunomagnetic separation
techniques.
MATERIALS AND METHODS
A. General Medium Requirement
RPMI 1640 medium + 10% (v/v) FBS, 2 mM glutamine, 1% (v/v)
nonessential amino acids, 1% (v/v) sodium pyruvate, 50 U/ml
penicillin, 50 mg/ml streptomycin, and 50 mg/ml kanamycin.
B. Thawing and Culturing Cells
1.
Prepare a 37ºC water bath to temperature.
2.
Keep all samples frozen until the bath is ready.
3.
Place the vials into the water bath, being careful not to
submerge below the junction between the lid and the vial.
4.
Place vial of cells in 37°C water bath and agitate until
thawed. It is important to thaw the cells quickly; do NOT
allow thawed cells to remain in freezing media any longer
than necessary.
5.
When only a small amount of ice remains, remove the vials
and dry with a lab tissue. Clean the top of the vial with a lab
tissue wetted with 70% alcohol; avoid wiping away the
labeling.
6.
Within about 30 sec., slowly add one milliliter of medium
(containing serum) to the thawed cells.
7.
Slowly add thawed cells to 8 ml of medium containing
serum. Invert tube 2 or 3 times to mix or mix gently by
pipetting up and down several times.
8.
Centrifuge for 5 min at 400 x g.
9.
Aspirate or decant the supernatant and gently resuspend the
cell pellet in 10 ml of medium.
10. Remove an aliquot for cell count and proceed with
experimental manipulations.
11. Culture the cells in RPMI 1640 medium supplemented with
10% (v/v) FBS, 2 mM glutamine, 1% (v/v) nonessential
amino acids, 1% (v/v) sodium pyruvate, 50 U/ml penicillin, 50
mg/ml streptomycin, and 50 mg/ml kanamycin at a density of
1-2 million cells/ml.
NOTE: The cell suspension may form clumps after standing
at room temperature. This can be avoided by preparing and
using the cells promptly or by adding DNase to the
suspension at a final concentration of 10 units per ml.
Normal Human CD8+ Cytotoxic T Cells, Manual
C. References
1. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell
functional responses. Ritu Sarin, Xingxin Wu, and Clara Abraham. PNAS, June 7, 201, Vol. 108, No. 23, 9560–9565.
The purchase price paid for the ImmunoPure™ HD cells and reagents grants end users a non-transferable, non-exclusive license to use the kit
and/or its components for internal in vitro research use only as described in this manual; in particular, “research use only” excludes and
without limitation, resale, repackaging, or use for the making or selling of any commercial product or service without the written approval of
Genlantis. Separate licenses are available for non-research use or applications. The PrimaPure™ HD cells and reagents are not to be
used in human diagnostic or therapeutic applications, including primary or secondary use to produce or derive, directly or indirectly,
any components used as drugs for human or animal use. Although routinely tested for HIV-1, HBV, HCV, Syphilis, and other infectious
diseases, these cells must be handled as potentially infectious. There is no test that can completely guarantee the absence of infectious
agents; care and attention should be exercised in handling the ImmunoPure cells by following standardized research lab practices, wearing
protective lab clothing, and using appropriate equipment.
Purchasers may refuse this license by returning the enclosed materials unused. By keeping or using the enclosed materials, you agree to be
bound by the terms of this license. The laws of the State of California shall govern the interpretation and enforcement of the terms of this
license.
Genlantis
Page 2 of 2
10190 Telesis Court. San Diego, CA 92121 • Toll Free (888) 428-0558 • U.S. & Canada (858) 457-1919 • www.genlantis.com
VKM120202
2011 Genlantis and Gene Therapy Systems, Inc.
Download PDF